A Randomised Investigation of Alternative Ofatumumab containing regimens in less fit patient with CLL.
Study Area: Haematology
Aim: A study for less fit or older patients with a new diagnosis of CCL, comparing ofatumumab + bendamustine with ofatumumab + chlorambucil to see which is most effective. Six cycles of chemotherapy and three monthly regular follow ups checking blood results and side effects.
Who can Participate: confirmed new diagnosis of chronic lynmhocycic leukaemia age 75 or older and/or other health problems such as heart issues or COPD.